Recombinant Human INSL4
Product Specifications
Product Name Alternative
Early Placenta Insulin-Like Peptide, EPIL, Insulin-Like Peptide 4, Placentin, INSL4
UniProt
Q14641
Expression Region
26-139
Host
Mammalian Cells
Tag
C-terminal His Tag
Applications
Western Blot, ELISA
Endotoxin
< 1 EU/µg as determined by LAL test.
Purity
Greater than 80% as determined by SDS-PAGE.
Form
Lyophilized powder
Reconstitution
Centrifuge the vial at 10000 rpm for 30 s before opening, reconstitute in sterile distilled water to a concentration of 0.1-1 mg/ml by gently pipetting 2-3 times, don't vortex.
Molecular Weight
9 kDa
Shipping Conditions
4°C with ice bag
Storage Conditions
The lyophilized protein is stable at -20 °C for up to 1 year. For extended storage, it is recommended to further dilute in working aliquots after reconstitution. The protein solution is stable at ≤ -20 °C for 3 months, or 2-7 days at 2-8 °C under sterile conditions.Avoid repeated freeze/thaw cycle.
Formulation
Lyophilized from a 0.2 μm filtered solution of 20 mM Tris, 150 mM NaCl, pH 8.0.
Organism Species
Human
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC200915L3V 200 µL
ABHD6 (NM_020676) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
T0294-06A 50 µg
TACI (Transmembrane Activator and CAML Interactor) (Control Peptide)
Sign In for Pricing
View Details 136919 100 µg
Leptin Receptor B, Control Peptide (ObRb, Obese Receptor B)
Sign In for Pricing
View Details